[18F]-2-(3-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propyl)-5-(2-fluoroethoxy)-3,4-dihydroisoquinolin-1(2H)-one

ID: ALA2437388

Chembl Id: CHEMBL2437388

PubChem CID: 73349550

Max Phase: Preclinical

Molecular Formula: C25H31FN2O4

Molecular Weight: 442.53

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OC)CN(CCCN1CCc3c(OCC[18F])cccc3C1=O)CC2

Standard InChI:  InChI=1S/C25H31FN2O4/c1-30-23-15-18-7-12-27(17-19(18)16-24(23)31-2)10-4-11-28-13-8-20-21(25(28)29)5-3-6-22(20)32-14-9-26/h3,5-6,15-16H,4,7-14,17H2,1-2H3/i26-1

Standard InChI Key:  LXZHKHWPFHAUAJ-KPVNRNJOSA-N

Associated Targets(non-human)

Bone (232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cerebellum (218 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cerebral cortex (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hippocampus (432 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 442.53Molecular Weight (Monoisotopic): 442.2268AlogP: 3.50#Rotatable Bonds: 9
Polar Surface Area: 51.24Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.65CX LogP: 2.88CX LogD: 2.44
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.60Np Likeness Score: -0.62

References

1. Abate C, Selivanova SV, Müller A, Krämer SD, Schibli R, Marottoli R, Perrone R, Berardi F, Niso M, Ametamey SM..  (2013)  Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ₂ receptors.,  69  [PMID:24161678] [10.1016/j.ejmech.2013.09.018]

Source